financial post
Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort
Financial Post • 4 MONTHS AGO
Economic decline due to tariffs weigh on Big 6 banks as they get set to report earnings
Financial Post • 4 MONTHS AGO
BT Group Advances Enterprise Service Innovation by Enabling Future-Proven Business Services With Optiva Platform
Financial Post • 4 MONTHS AGO
Western Upper Peninsula Communities Demonstrate Continued Support for the Copperwood Mine Project
Financial Post • 4 MONTHS AGO
Colliers makes 19th consecutive appearance on IAOP’s Global Outsourcing 100
Financial Post • 4 MONTHS AGO
Purpose Investments Expands Yield Shares Lineup with Seven New ETFs, Offering Enhanced Income Opportunities
Financial Post • 4 MONTHS AGO